Dr. Stadtmauer on Current Challenges With Multiple Myeloma

Edward A. Stadtmauer, MD
Published: Thursday, Nov 02, 2017



Edward A. Stadtmauer, MD, section chief of Hematologic Malignancies, Abramson Cancer Center, University of Pennsylvania, discusses the current challenges with multiple myeloma.

The biggest challenge with multiple myeloma is understanding which combinations or sequences to use with these field-changing agents, explains Stadtmauer.

Ongoing trials are helping oncologists understand more about when and how long to treat patients with these agents. Stadtmauer says he is hopeful about the outcome for patients with multiple myeloma.


Edward A. Stadtmauer, MD, section chief of Hematologic Malignancies, Abramson Cancer Center, University of Pennsylvania, discusses the current challenges with multiple myeloma.

The biggest challenge with multiple myeloma is understanding which combinations or sequences to use with these field-changing agents, explains Stadtmauer.

Ongoing trials are helping oncologists understand more about when and how long to treat patients with these agents. Stadtmauer says he is hopeful about the outcome for patients with multiple myeloma.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and VomitingOct 31, 20182.0
Publication Bottom Border
Border Publication
x